SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert S. who wrote (7542)10/26/1998 9:46:00 PM
From: aknahow  Read Replies (2) | Respond to of 17367
 
Robert S, I see your point. Thanks much. Think Dr. Giroir has said about the same thing. Real world conditions will permit quicker use of Neuprex than do the current trial designs. Good point. Think many of us would have missed it! No more waiting for patient to reach 8 on the Glasgow scale etc. etc.



To: Robert S. who wrote (7542)10/26/1998 10:35:00 PM
From: Robert K.  Read Replies (1) | Respond to of 17367
 
Real world >see Cacaito note 5787 and lets not forget diagnostics.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News